Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone
... and 1565 mg, human equivalent dosage) actually stunted the
lifespan of mice. So the public has been misled concerning dosage since 2006
[Nature 2006 nov
16; 444:337-42], and may have never heard about the 2008
report, says Sardi.
Lower dose resveratrol accompanied by an array of other small mole...
SARS Vaccine Achieves Neutralizing Responses in First U.S. Human Trial
... JE et al. A SARS DNA vaccine induces neutralizing antibody and
cellular immune responses in healthy adults in a Phase I clinical trial.
Vaccine. 2008 nov
Contact: Alan R. Engbring
Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia
...an Francisco, CA.
(3) Gleevec(R) (imatinib mesylate) tablets prescribing information. East
Hanover, NJ: Novartis Pharmaceuticals Corporation; nov
*Known as Glivec(R) (imatinib) outside the US, Canada and Israel.
Two New Studies in the New England Journal of Medicine Show Malaria Vaccine Candidate Advancing in Africa
.... N Engl J Med 2008;359:
(3) World Health Organization. World Malaria Report 2008, Sept 2008.
http://malaria.who.int/wmr2008 . Last accessed: nov
(4) Aponte JJ, Aide P, Renom M, et al. Safety of the RTS,S/AS02D candidate
malaria vaccine in infants living in a highly endemic area of ...
Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease
...ng information. East Hanover, NJ: Novartis Pharmaceuticals Corporation; nov
2007. 7. Gleevec(R) (imatinib mesylate) tablets prescribing information. East Hanover, NJ: Novartis Pharmaceuticals Corporation; nov
Novartis Media Relations
Media Contacts Media only: ...
Long-Term Safety and Efficacy Data on Promacta(TM) (Eltrombopag) Presented at American Society of Hematology Annual Meeting
...treatment of subjects with idiopathic
thrombocytopenic purpura (ITP): preliminary data from the EXTEND study.
Blood. 2007; 110 (11). Published online, nov
(2) McMillan, R., Bussel, JB., et al. Self-reported health-related
quality of life in adults with chronic immune thrombocytopenic purpura. Am
Kronos Announces First Quarter Business Update and Financial Results
... BELMONT, Mass., nov
15 /PRNewswire-FirstCall/ -- Kronos Advanced
Technologies, Inc. (OTC Bulletin Board: KNOS) President and Chief Executive
Officer, Daniel R. Dwight, re...
American Legion Anticipates Institute of Medicine Report on Gulf War Veterans
...wswire/ -- The American Legion
welcomes the findings of an Institute of Medicine (IOM) report on
Deployment Related Stress scheduled to be released on nov
"In view of the serious and widespread impact of stress on the health
of military personnel who have served in Iraq and Afghanistan, this focus
Positive Results Prompt US National Cancer Institute to Make
Gleevec Available To Patients in Post-Surgical Gist Study
1 Gleevec(R) (imatinib mesylate) tablets prescribing
information. East Hanover, NJ: Novartis Pharmaceuticals
Media only: Investors only:
Gloria Stone Jill Pozarek
Novartis Oncology ...